ims class assignment

19
Data. Insights. Results. 1

Upload: mohamed-kadri

Post on 03-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 1/19

Data. Insights. Results.

1

Page 2: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 2/19

2

PRESENTATION FOR 

MARKETING RESEARCH

COMPANY. 

Submitted to:

Dr.Wafaa Marzouk

Done by:

Mohamed Kadri & Ahmed Mahdy.

22 Feb 2009

ASSIGNMENT DESCRIPTION

Page 3: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 3/19

3

Intercontinental Marketing Services

Pharmaceutical companies face extraordinary

competition for market share and pressures to

maximize brand lifecycles, all while proving the

value of their medicines.

IMS can apply insight and capabilities to a

tremendously rich set of data assets and analytics.

Page 4: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 4/19

4

IMS HISTORY

Back in 1954, Bill Frohlich, an advertising executive,

and David Dubow, a visionary, set out to create anew kind of information company that could enable

organizations to make informed, strategic decisions

about the marketplace. They called their venture

Intercontinental Marketing Services.

IMS today is recognized as the leader in its field — the world’s leading provider of market intelligence to

the pharmaceutical and healthcare industries.

Page 5: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 5/19

5

Strategy: Innovation Drives Growth

By 1957, IMS had published its first European

syndicated research study, an audit of 

pharmaceutical sales within the West German

market. Its utility and popularity prompted IMS

to expand into new geographies— Great

Britain, France, Italy, Spain, and Japan among

them. Subsequent acquisitions in South Africa,

Australia, and New Zealand strengthened theIMS position, and by 1969, IMS, with an annual

revenue of $5 million, had established the gold

standard in pharmaceutical market research in

Europe and Asia.

Page 6: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 6/19

6

Strategy: Innovation Drives Growth

By 1981, IMS was a thriving worldwide company with

offices in 57 countries and annual revenues of $170 

million.

It was also a company at a crossroads — a company that

soon elected to reestablish itself as a company solely 

focused on healthcare by shedding its consumer researchinterests.

Page 7: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 7/19

60% Non–USRevenues

Operate in Over100 Countries 

Over 1 Million DrugProducts Tracked

Over 2,500 PharmaManufacturersSupported

Global Leadershipfor 50 Years

Our Profile . . .

Our Profile...

7

225,000Data Sources

Page 8: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 8/19

Page 9: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 9/19

9

 IMS Scope

At IMS,it works with nearly every major

pharmaceutical and biotech company in the

world on projects ranging from portfolio

development to product lifecycle management.

It also provide information, analytics and

consulting to a growing range of other

organizations with a stake in global healthcare.

They also have an internet service(59website).

Page 10: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 10/19

1997 2001 2006

N. America Europe Japan Other

$387B

$618B

$296B

10

Pharma Industry Growth

1997-2006

Page 11: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 11/19

GlobalExecution

Marketing

Pharmaceutical Industry Challenges

Sales

ThePipeline

Managing the Life Cycle& New Drugs Drive Growth.

Maximize Revenue from Portfolio

Transformation& Productivity of Representative.

A More Complex Mix.

Unique Tactics & Speed.

Pharmaceutical Challenges

11

Page 12: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 12/19

12

These trends help drive our strategy . . .

Opportunities for IMS

More Solutions to Optimize Sales.

More Detailed and Precise Data, New Data.

More Integration of All Information Sources.

More Customization of Applications.

More Diverse Users Need to be Served.

Page 13: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 13/19

Page 14: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 14/19

Integrated Applications

Consulting

Data

14

IMS Territory Planner

 “How am I doing against the competition?”  

Page 15: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 15/19

Integrated Applications

Consulting

Data

15

IMS Territory Planner

 “How effective are my calls?”  

Page 16: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 16/19

Integrated Applications

Consulting

Data

16

IMS Strategy Evaluator

Random targeting

% of potential sales

increase 

Perfect targeting

0%

20%

40%

60%

80%

100%

Usual targeting

conducted by majority of 

pharmaceutical

companies

0% 20% 40% 60% 80% 100%

% customers visited 

Opportunity

Illustrative Example

Page 17: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 17/19

17

IMS Core Strengths

People

Reputation of Leadership and Innovation.

Customer Base.

Unmatched Data Assets and Expertise.

Solutions.

Global Coverage.

Financial Model.

Page 18: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 18/19

18

 IMS Egypt 

8, Khaled Ibn El Walid St.

Sheraton Area, Helipolis

Cairo

Egypt

Tel: +20 (2) 22 66 17

IMS HEADQUARTER,EGYPT

Corporate Headquarters

901 Main Avenue

Suite 612

Norwalk, CT 06851-1187

USA

Tel: 1 (203) 845-5200Sales & 

Marketing 

Page 19: IMS Class Assignment

7/28/2019 IMS Class Assignment

http://slidepdf.com/reader/full/ims-class-assignment 19/19

© 2002 IMS Health Incorporated or its affiliates. All ri ghts reserved.19